Gyan Barik: First-In-Human Trial for Axana Stroke Detection Is Complete
Gyan Barik, Executive Director at Wellumio, shared Wellumio‘s post on LinkedIn, adding:
”Thrilled to share: Wellumio’s FIRST-IN-HUMAN trial for Axana stroke detection tech is COMPLETE at Royal Melbourne Hospital!
A game-changer for faster stroke decisions, huge thanks to participants, families, RMH teams (shoutout Dr James Barker, Amy MacDonald, Profs Geoffrey Donnan and Stephen Davis), and all partners.
Invaluable insights gained.
Phase 2, here we come!”
Quoting Wellumio‘s post:
”We’re very excited to announce the completion of our first-in-human clinical trial at The Royal Melbourne Hospital.
This is a major milestone and a significant step forward for Axana as we work to accelerate stroke detection and decision-making in time-critical settings.
First and foremost, we thank the study participants and their families.
This study would not have been possible without their generosity and willingness to support the advancement of medical technology.
We are also incredibly grateful to the clinicians, investigators, and research teams at RMH, along with all of our collaborators and partners who helped make this possible.
In particular, we’d like to acknowledge Dr James Barker and Amy MacDonald for coordinating the study day to day, and Professors Geoffrey Donnan and Stephen Davis from the Australian Stroke Alliance as the site Principal Investigators.
This trial has generated invaluable insights, and we’re looking forward to returning to the clinic for our Phase 2 trial.”
Stay updated with Hemostasis Today.
-
Oct 21, 2026, 07:15Mahmoud Saad: Successful Mechanical Thrombectomy for Right Atrial Thrombosis
-
Oct 21, 2026, 06:55Hunain Shahbaz: Extended Dual Antiplatelet Therapy Beyond 12 Months After Drug-Eluting Stent Implantation
-
Oct 21, 2026, 06:19Dawood Findakly: When Should Anticoagulation Be Held or Resumed?
-
Oct 21, 2026, 03:36Steve Watson: Ligand Epitope Ratios Influence Antagonist Inhibition
-
Oct 21, 2026, 03:18Stephen D. Coombs: Superficial Venous Thrombosis in Athletes and Importance of Early Recognition and Referral
-
Oct 21, 2026, 02:52Aymar Akilimali: Bleeding During Anticoagulation as a Potential Signal of Occult Cancer
-
Oct 21, 2026, 00:58Anees Ur Rahman: Completing a Two-Week Clinical Rotation at Haemophilia Treatment Centre Rawalpindi
-
Oct 21, 2026, 00:56Caitlyn Mooney: Pulmonary Embolism in Athletes, Recognition and Return to Sport
-
Oct 21, 2026, 00:54Hani Karrar: Pleased to Share Our Review on Emicizumab in Hemophilia A Management